158 related articles for article (PubMed ID: 11994475)
1. Costimulation of host T lymphocytes by a trypanosomal trans-sialidase: involvement of CD43 signaling.
Todeschini AR; Nunes MP; Pires RS; Lopes MF; Previato JO; Mendonça-Previato L; DosReis GA
J Immunol; 2002 May; 168(10):5192-8. PubMed ID: 11994475
[TBL] [Abstract][Full Text] [Related]
2. trans-Sialidase from Trypanosoma cruzi binds host T-lymphocytes in a lectin manner.
Todeschini AR; Girard MF; Wieruszeski JM; Nunes MP; DosReis GA; Mendonca-Previato L; Previato JO
J Biol Chem; 2002 Nov; 277(48):45962-8. PubMed ID: 12237289
[TBL] [Abstract][Full Text] [Related]
3. Enzymatically inactive trans-sialidase from Trypanosoma cruzi binds sialyl and beta-galactopyranosyl residues in a sequential ordered mechanism.
Todeschini AR; Dias WB; Girard MF; Wieruszeski JM; Mendonça-Previato L; Previato JO
J Biol Chem; 2004 Feb; 279(7):5323-8. PubMed ID: 14634017
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.
Freire-de-Lima L; Alisson-Silva F; Carvalho ST; Takiya CM; Rodrigues MM; DosReis GA; Mendonça-Previato L; Previato JO; Todeschini AR
J Biol Chem; 2010 Apr; 285(18):13388-96. PubMed ID: 20106975
[TBL] [Abstract][Full Text] [Related]
5. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
Gao W; Pereira MA
Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
Millar AE; Kahn SJ
Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
9. The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen.
Millar AE; Kahn SJ
Infect Immun; 2000 Jun; 68(6):3574-80. PubMed ID: 10816514
[TBL] [Abstract][Full Text] [Related]
10. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo.
Leguizamón MS; Mocetti E; García Rivello H; Argibay P; Campetella O
J Infect Dis; 1999 Oct; 180(4):1398-402. PubMed ID: 10479182
[TBL] [Abstract][Full Text] [Related]
11. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
Tonelli RR; Torrecilhas AC; Jacysyn JF; Juliano MA; Colli W; Alves MJ
Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
[TBL] [Abstract][Full Text] [Related]
13. Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity.
Cremona ML; Campetella O; Sánchez DO; Frasch AC
Glycobiology; 1999 Jun; 9(6):581-7. PubMed ID: 10336990
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of an enzymatically inactive trans-sialidase-like lectin from Trypanosoma cruzi: the carbohydrate binding mechanism involves residual sialidase activity.
Oppezzo P; Obal G; Baraibar MA; Pritsch O; Alzari PM; Buschiazzo A
Biochim Biophys Acta; 2011 Sep; 1814(9):1154-61. PubMed ID: 21570497
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
16. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
Padilla A; Xu D; Martin D; Tarleton R
Infect Immun; 2007 Jan; 75(1):231-5. PubMed ID: 17043105
[TBL] [Abstract][Full Text] [Related]
17. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
18. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
19. Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.
Ming M; Chuenkova M; Ortega-Barria E; Pereira ME
Mol Biochem Parasitol; 1993 Jun; 59(2):243-52. PubMed ID: 8341323
[TBL] [Abstract][Full Text] [Related]
20. Trans-sialidase-like sequences from Trypanosoma congolense conserve most of the critical active site residues found in other trans-sialidases.
Tiralongo E; Martensen I; Grötzinger J; Tiralongo J; Schauer R
Biol Chem; 2003 Aug; 384(8):1203-13. PubMed ID: 12974389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
